NCT05594264 is a NA clinical trial of HBPStories in Hypertension, sponsored by University of Delaware.

Who is sponsoring NCT05594264?

NCT05594264 is sponsored by University of Delaware.

What drugs are being tested in NCT05594264?

Interventions in NCT05594264: HBPStories.

What condition does NCT05594264 study?

NCT05594264 studies Hypertension.

Is NCT05594264 still recruiting?

NCT05594264 is currently terminated. Last updated 8 October 2024.

Are results published for NCT05594264?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-10-08 · How we verify

NCT05594264

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Storytelling Intervention for African Americans Living With Hypertension

Terminated NA Results posted Last updated 8 October 2024

What this trial tests

NA trial testing HBPStories in Hypertension in 31 participants. Terminated before completion.

Timeline

14 July 2022

Primary endpoint
24 June 2023

24 June 2023

Quick facts

Lead sponsor	University of Delaware
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	31
Start date	14 July 2022
Primary completion	24 June 2023
Estimated completion	24 June 2023
Sites	1 location across United States

Drugs / interventions tested

HBPStories

Conditions studied

Hypertension — all drugs for Hypertension →

Sponsor

University of Delaware

Who can join

18 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Narrative communication (e.g., storytelling) is an approach that has contributed to behavioral change for individuals with conditions such as diabetes, breast cancer, and hypertension. The objective of this study is to conduct a feasibility and pilot study storytelling intervention for African Americans with hypertension. In the feasibility phase 30 African Americans with hypertension will be recruited to view nine patient stories and provide feedback on the effectiveness, usefulness, and satisfaction with the stories. Nine African Americans adults with hypertension were filmed, sharing experiences living with and managing hypertension; including, diet and exercise tips, suggestions for locating healthy foods, and motivational stories about successfully controlling hypertension. During the feasibility phase feedback will also be elicited from the participants about the best approaches for delivering a storytelling intervention, and obtain feedback on the resources and health information that would be helpful to an individual participating in a storytelling intervention. In the pilot study phase, 30 African Americans adults with hypertension will be recruited to participate in a 6-week trial, each week the participants will watch one story and review one module of health information accessible through the study specific website developed for the High Blood Pressure Stories (HBPStories) study. Data will be collected at baseline and 6-weeks including systolic and diastolic blood pressure, medication adherence, health behaviors such as diet and physical activity, and psychosocial measures including positive affect and self-efficacy in the management of hypertension.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other University of Delaware trials

Trials by the same sponsor.

NCT07420218 — Menopausal Hormones and Sympathetic Activation · Phase 4 · not yet recruiting
NCT07536217 — Developmental Pilot of Support Groups for Caregivers of Children With DLD · NA · enrolling by invitation
NCT07054840 — Pain and Split-belt Motor Learning in Older Adults · NA · recruiting
NCT06916260 — Light Therapy Intervention in Individuals With Parkinson's Disease · NA · recruiting
NCT07071077 — Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05594264 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Delaware
Last refreshed: 8 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05594264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing